Picture of Aravive logo

ARAV Aravive Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Aravive, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-76.3-18.2-30.5-39.2-76.3
Depreciation
Non-Cash Items54.53.49.132.2612.3
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-8.44-2.767.413.74-1.91
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-29.3-17.1-12.2-32.2-65.1
Capital Expenditures-0.033-0.011
Purchase of Fixed Assets
Other Investing Cash Flow Items3.20
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities3.170-0.011
Financing Cash Flow Items1.94.920
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities1.9525.37.5831.159.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-24.18.17-4.59-1.12-5.72